Stoke Ther­a­peu­tics’ par­tial hold lift­ed; Re­cur­sion gets $30M from Roche

Plus, news about Seres Ther­a­peu­tics, Nestlé Health Sci­ence, Pfiz­er, Evotec and Re­lay Ther­a­peu­tics:

FDA lifts par­tial hold on Stoke Ther­a­peu­tics’ Dravet syn­drome drug: …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER